BMRN logo

BioMarin Pharmaceutical (BMRN) CAPEX

annual CAPEX:

$97.42M-$10.19M(-9.47%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual capital expenditures is $97.42 million, with the most recent change of -$10.19 million (-9.47%) on December 31, 2024.
  • During the last 3 years, BMRN annual CAPEX has fallen by -$21.81 million (-18.29%).
  • BMRN annual CAPEX is now -57.21% below its all-time high of $227.65 million, reached on December 31, 2015.

Performance

BMRN CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

quarterly CAPEX:

$16.77M-$3.53M(-17.39%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly capital expenditures is $16.77 million, with the most recent change of -$3.53 million (-17.39%) on March 31, 2025.
  • Over the past year, BMRN quarterly CAPEX has dropped by -$17.34 million (-50.83%).
  • BMRN quarterly CAPEX is now -83.85% below its all-time high of $103.81 million, reached on December 31, 2015.

Performance

BMRN quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

TTM CAPEX:

$80.08M-$17.34M(-17.80%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN TTM capital expenditures is $80.08 million, with the most recent change of -$17.34 million (-17.80%) on March 31, 2025.
  • Over the past year, BMRN TTM CAPEX has dropped by -$36.87 million (-31.52%).
  • BMRN TTM CAPEX is now -65.03% below its all-time high of $229.03 million, reached on March 31, 2016.

Performance

BMRN TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

BMRN CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.5%-50.8%-31.5%
3 y3 years-18.3%-45.3%-34.2%
5 y5 years-40.4%-61.9%-53.9%

BMRN CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-25.9%at low-54.3%at low-42.6%at low
5 y5-year-40.4%at low-62.2%at low-53.9%at low
alltimeall time-57.2%+2490.9%-83.8%+3453.6%-65.0%>+9999.0%

BMRN CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$16.77M(-17.4%)
$80.08M(-17.8%)
Dec 2024
$97.42M(-9.5%)
$20.30M(-4.1%)
$97.42M(-14.4%)
Sep 2024
-
$21.18M(-3.0%)
$113.81M(-1.9%)
Jun 2024
-
$21.84M(-36.0%)
$116.06M(-0.8%)
Mar 2024
-
$34.10M(-7.1%)
$116.95M(+8.7%)
Dec 2023
$107.61M(-18.2%)
$36.70M(+56.7%)
$107.61M(+0.3%)
Sep 2023
-
$23.42M(+3.0%)
$107.27M(-10.8%)
Jun 2023
-
$22.73M(-8.2%)
$120.33M(-4.2%)
Mar 2023
-
$24.77M(-31.9%)
$125.63M(-4.5%)
Dec 2022
$131.54M(+10.3%)
$36.36M(-0.3%)
$131.54M(-5.7%)
Sep 2022
-
$36.47M(+30.1%)
$139.54M(+13.1%)
Jun 2022
-
$28.04M(-8.6%)
$123.43M(+1.5%)
Mar 2022
-
$30.68M(-30.8%)
$121.65M(+2.0%)
Dec 2021
$119.22M(-13.3%)
$44.36M(+117.9%)
$119.22M(+3.9%)
Sep 2021
-
$20.36M(-22.4%)
$114.73M(+0.2%)
Jun 2021
-
$26.25M(-7.1%)
$114.52M(-5.9%)
Mar 2021
-
$28.25M(-29.1%)
$121.76M(-11.5%)
Dec 2020
$137.52M(-15.8%)
$39.86M(+97.8%)
$137.52M(-13.2%)
Sep 2020
-
$20.15M(-39.8%)
$158.50M(-8.8%)
Jun 2020
-
$33.48M(-23.9%)
$173.75M(-1.8%)
Mar 2020
-
$44.02M(-27.7%)
$176.96M(+8.3%)
Dec 2019
$163.41M(+13.0%)
$60.84M(+71.8%)
$163.41M(+13.0%)
Sep 2019
-
$35.41M(-3.5%)
$144.64M(-9.1%)
Jun 2019
-
$36.70M(+20.5%)
$159.09M(+9.8%)
Mar 2019
-
$30.46M(-27.6%)
$144.92M(+0.2%)
Dec 2018
$144.62M(-27.4%)
$42.08M(-15.6%)
$144.62M(+1.5%)
Sep 2018
-
$49.86M(+121.4%)
$142.43M(+5.5%)
Jun 2018
-
$22.52M(-25.3%)
$135.05M(-15.7%)
Mar 2018
-
$30.16M(-24.4%)
$160.29M(-19.5%)
Dec 2017
$199.22M(+34.3%)
$39.89M(-6.1%)
$199.22M(-5.5%)
Sep 2017
-
$42.48M(-11.0%)
$210.90M(+8.4%)
Jun 2017
-
$47.76M(-30.9%)
$194.52M(+12.9%)
Mar 2017
-
$69.09M(+34.0%)
$172.27M(+16.1%)
Dec 2016
$148.38M(-34.8%)
$51.57M(+97.6%)
$148.38M(-26.0%)
Sep 2016
-
$26.10M(+2.3%)
$200.62M(-8.4%)
Jun 2016
-
$25.51M(-43.6%)
$219.07M(-4.3%)
Mar 2016
-
$45.20M(-56.5%)
$229.03M(+0.6%)
Dec 2015
$227.65M(+94.5%)
$103.81M(+133.0%)
$227.65M(+50.2%)
Sep 2015
-
$44.56M(+25.7%)
$151.61M(+14.7%)
Jun 2015
-
$35.46M(-19.1%)
$132.22M(-3.7%)
Mar 2015
-
$43.83M(+57.9%)
$137.29M(+17.3%)
Dec 2014
$117.06M(+79.6%)
$27.77M(+10.3%)
$117.06M(-1.7%)
Sep 2014
-
$25.17M(-37.9%)
$119.05M(+11.2%)
Jun 2014
-
$40.52M(+71.6%)
$107.08M(+39.1%)
Mar 2014
-
$23.61M(-20.7%)
$76.97M(+18.1%)
Dec 2013
$65.19M(+46.3%)
$29.75M(+125.4%)
$65.19M(+32.1%)
Sep 2013
-
$13.20M(+26.8%)
$49.34M(-3.5%)
Jun 2013
-
$10.41M(-12.0%)
$51.15M(+1.8%)
Mar 2013
-
$11.83M(-14.9%)
$50.22M(+12.7%)
Dec 2012
$44.57M(-71.1%)
$13.89M(-7.4%)
$44.57M(-63.0%)
Sep 2012
-
$15.01M(+58.3%)
$120.36M(-25.6%)
Jun 2012
-
$9.48M(+53.5%)
$161.73M(+4.9%)
Mar 2012
-
$6.18M(-93.1%)
$154.16M(-0.0%)
DateAnnualQuarterlyTTM
Dec 2011
$154.22M(+211.8%)
$89.68M(+59.0%)
$154.22M(+104.9%)
Sep 2011
-
$56.39M(+2852.3%)
$75.28M(+166.3%)
Jun 2011
-
$1.91M(-69.4%)
$28.26M(-32.0%)
Mar 2011
-
$6.24M(-41.9%)
$41.59M(-15.9%)
Dec 2010
$49.46M(-44.9%)
$10.74M(+14.6%)
$49.46M(-19.4%)
Sep 2010
-
$9.37M(-38.5%)
$61.34M(-21.9%)
Jun 2010
-
$15.24M(+8.0%)
$78.53M(-7.8%)
Mar 2010
-
$14.11M(-37.6%)
$85.17M(-5.2%)
Dec 2009
$89.80M(+59.3%)
$22.62M(-14.8%)
$89.80M(+13.5%)
Sep 2009
-
$26.56M(+21.4%)
$79.10M(+22.3%)
Jun 2009
-
$21.88M(+16.8%)
$64.66M(+17.1%)
Mar 2009
-
$18.74M(+57.2%)
$55.22M(-2.0%)
Dec 2008
$56.37M(+151.5%)
$11.92M(-1.6%)
$56.37M(+3.7%)
Sep 2008
-
$12.11M(-2.7%)
$54.38M(+13.5%)
Jun 2008
-
$12.44M(-37.4%)
$47.92M(+22.7%)
Mar 2008
-
$19.89M(+100.2%)
$39.07M(+74.3%)
Dec 2007
$22.41M(-8.8%)
$9.94M(+75.9%)
$22.41M(+42.8%)
Sep 2007
-
$5.65M(+57.2%)
$15.69M(+25.4%)
Jun 2007
-
$3.59M(+11.1%)
$12.51M(-53.6%)
Mar 2007
-
$3.23M(+0.6%)
$26.95M(+9.6%)
Dec 2006
$24.58M(+279.0%)
$3.22M(+30.3%)
$24.58M(-6.5%)
Sep 2006
-
$2.47M(-86.3%)
$26.30M(+8.0%)
Jun 2006
-
$18.03M(+1974.6%)
$24.35M(+259.5%)
Mar 2006
-
$869.00K(-82.4%)
$6.77M(+4.4%)
Dec 2005
$6.49M(-73.1%)
$4.94M(+864.6%)
$6.49M(-29.7%)
Sep 2005
-
$512.00K(+13.0%)
$9.22M(-52.6%)
Jun 2005
-
$453.00K(-22.2%)
$19.46M(-16.9%)
Mar 2005
-
$582.00K(-92.4%)
$23.43M(-2.7%)
Dec 2004
$24.07M(+302.9%)
$7.67M(-28.6%)
$24.07M(+22.0%)
Sep 2004
-
$10.75M(+143.1%)
$19.74M(+81.8%)
Jun 2004
-
$4.42M(+258.8%)
$10.86M(+54.3%)
Mar 2004
-
$1.23M(-63.1%)
$7.04M(+17.8%)
Dec 2003
$5.97M(+22.9%)
$3.34M(+79.0%)
$5.97M(+92.0%)
Sep 2003
-
$1.86M(+209.8%)
$3.11M(+316.6%)
Jun 2003
-
$602.00K(+254.1%)
$747.00K(-73.2%)
Mar 2003
-
$170.00K(-64.2%)
$2.79M(-42.7%)
Dec 2002
$4.86M(-72.7%)
$475.00K(-195.0%)
$4.86M(-57.0%)
Sep 2002
-
-$500.00K(-118.9%)
$11.30M(-37.6%)
Jun 2002
-
$2.64M(+17.6%)
$18.11M(-7.7%)
Mar 2002
-
$2.25M(-67.5%)
$19.63M(+10.2%)
Dec 2001
$17.81M(+373.7%)
$6.91M(+9.4%)
$17.81M(+40.3%)
Sep 2001
-
$6.32M(+51.9%)
$12.70M(+79.6%)
Jun 2001
-
$4.16M(+866.5%)
$7.07M(+97.4%)
Mar 2001
-
$430.00K(-76.1%)
$3.58M(-4.7%)
Dec 2000
$3.76M(-83.6%)
$1.80M(+161.7%)
$3.76M(-35.2%)
Sep 2000
-
$687.00K(+3.0%)
$5.81M(-53.2%)
Jun 2000
-
$667.00K(+9.7%)
$12.42M(-40.2%)
Mar 2000
-
$608.00K(-84.2%)
$20.77M(-9.5%)
Dec 1999
$22.94M(+258.5%)
$3.84M(-47.3%)
$22.94M(+20.1%)
Sep 1999
-
$7.30M(-19.1%)
$19.10M(+61.9%)
Jun 1999
-
$9.02M(+224.3%)
$11.80M(+324.3%)
Mar 1999
-
$2.78M
$2.78M
Dec 1998
$6.40M
-
-

FAQ

  • What is BioMarin Pharmaceutical annual capital expenditures?
  • What is the all time high annual CAPEX for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual CAPEX year-on-year change?
  • What is BioMarin Pharmaceutical quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly CAPEX year-on-year change?
  • What is BioMarin Pharmaceutical TTM capital expenditures?
  • What is the all time high TTM CAPEX for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM CAPEX year-on-year change?

What is BioMarin Pharmaceutical annual capital expenditures?

The current annual CAPEX of BMRN is $97.42M

What is the all time high annual CAPEX for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual capital expenditures is $227.65M

What is BioMarin Pharmaceutical annual CAPEX year-on-year change?

Over the past year, BMRN annual capital expenditures has changed by -$10.19M (-9.47%)

What is BioMarin Pharmaceutical quarterly capital expenditures?

The current quarterly CAPEX of BMRN is $16.77M

What is the all time high quarterly CAPEX for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly capital expenditures is $103.81M

What is BioMarin Pharmaceutical quarterly CAPEX year-on-year change?

Over the past year, BMRN quarterly capital expenditures has changed by -$17.34M (-50.83%)

What is BioMarin Pharmaceutical TTM capital expenditures?

The current TTM CAPEX of BMRN is $80.08M

What is the all time high TTM CAPEX for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM capital expenditures is $229.03M

What is BioMarin Pharmaceutical TTM CAPEX year-on-year change?

Over the past year, BMRN TTM capital expenditures has changed by -$36.87M (-31.52%)
On this page